Tag: STEMI

1. Based on data from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines (ACTION Registry-GWTG), only one-half of all patients who required transfer for STEMI received primary percutaneous coronary intervention (pPCI) within 120 minutes. As the drive time increased to between 30 and 120 minutes,...
1. This meta-analysis of outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI) showed that women fared similarly to men in terms of hospital mortality and 1-year mortality, after adjusting for major confounding variables. 2. There were major differences in the baseline characteristics between women and men,...
1. Using cardiac magnetic resonance imaging (MRI), an association was found between infarct severity in patients with reperfused ST segment elevation myocardial infarction (STEMI) and poorer functional recovery of the left ventricle (LV). 2. Cardiac biomarker assessment showed that the presence of microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH)...
1. Patients with STEMI who underwent coronary artery thrombus aspiration before PCI did not have a significant reduction in mortality at 1 year of follow up. 2. Patients with STEMI who underwent thrombus aspiration before PCI did not have a significant reduction in the incidence of the composite of...
Image: PD 1. The early addition of clopidogrel significantly reduced the incidence of infarct-related arterial re-occlusion within 30 days following myocardial infarction 2. Addition of early clopidogrel improved the outcomes of coronary angiography and decreased the need for early/emergent angiography during the event 3. There were no differences in major or minor...
Image: PD  1. Bivalirudin, initiated during transport for primary PCI in patients with STEMI, improved 30-day clinical outcomes with a reduction in major bleeding.  2. The risk of acute stent thrombosis was higher with bivalirudin, compared to unfractionated or low-molecular-weight heparin and optional glycoprotein IIb/IIIa inhibitors.  Evidence Rating Level: 1 (Excellent)  Study Rundown:...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI For ST elevation myocardial infarctions (STEMI), percutanous coronary intervention (PCI) is recommend with strong evidence for benefit for a door-to-balloon time...
Image: PD  1. Among patients diagnosed with non ST-segment elevation myocardial infarction (NSTEMI) independent of cardiac troponin levels, 26% of patients did not meet the >20% delta criteria for diagnosis.  2. NSTEMI patients not meeting the delta troponin criteria were more likely to present with primary symptoms other than chest pain...
Image: CC/JHeauser 1. For early STEMI patients who could not undergo timely PCI within 1 hour, prehospital fibrinolysis coupled with coronary angiography was non-inferior to PCI. 2. Fibrinolytic therapy was associated with an increased risk of stroke and intracranial hemorrhage. This multi-center randomized control study randomized patients with early STEMI who could...